因此,我们提出了几种二硫代氨基甲酸酯钌(II)和钌(III)配合物的合成。从Na [反式Ru III(dmso)2 Cl 4 ](2)和顺式[Ru II(dmso)4 Cl 2 ](3)前驱体开始,即反磁性混合配体[Ru II L 2(dmso) )2 ]配合物4和5,顺磁性,中性[Ru III L 3 ]单体6和7,反铁磁耦合的离子α-[Ru III 2 L 5 ] Cl络合物8和9以及β-[Ru III 2 L 5 ] Cl双核物质10和11(L =二甲基-(DMDT)和吡咯烷二硫代氨基甲酸酯(PDT ))。所有化合物均通过元素分析以及1 H NMR和FTIR光谱进行了全面表征。此外,对于第一次的双核β-的[Ru晶体结构III 2(DMDT)5 ] BF 4 ⋅氯仿3 ⋅ CH 3CN和新型[Ru II L 2(dmso)2 ]配合物也已确定和讨论。对于单核和双核Ru II和Ru II
Ruthenium(II/III)-Based Compounds with Encouraging Antiproliferative Activity against Non-small-Cell Lung Cancer
作者:Eszter M. Nagy、Andrea Pettenuzzo、Giulia Boscutti、Luciano Marchiò、Lisa Dalla Via、Dolores Fregona
DOI:10.1002/chem.201202171
日期:2012.11.5
spectroscopy. Moreover, for the first time the crystal structures of the dinuclear β‐[RuIII2(dmdt)5]BF4⋅CHCl3⋅ CH3CN and of the novel [RuIIL2(dmso)2] complexes were also determined and discussed. For both the mono‐ and dinuclear RuII and RuIII complexes the central metal atoms assume a distorted octahedral geometry. Furthermore, in vitro cytotoxicity of the complexes has been evaluated on non‐small‐cell lung cancer
因此,我们提出了几种二硫代氨基甲酸酯钌(II)和钌(III)配合物的合成。从Na [反式Ru III(dmso)2 Cl 4 ](2)和顺式[Ru II(dmso)4 Cl 2 ](3)前驱体开始,即反磁性混合配体[Ru II L 2(dmso) )2 ]配合物4和5,顺磁性,中性[Ru III L 3 ]单体6和7,反铁磁耦合的离子α-[Ru III 2 L 5 ] Cl络合物8和9以及β-[Ru III 2 L 5 ] Cl双核物质10和11(L =二甲基-(DMDT)和吡咯烷二硫代氨基甲酸酯(PDT ))。所有化合物均通过元素分析以及1 H NMR和FTIR光谱进行了全面表征。此外,对于第一次的双核β-的[Ru晶体结构III 2(DMDT)5 ] BF 4 ⋅氯仿3 ⋅ CH 3CN和新型[Ru II L 2(dmso)2 ]配合物也已确定和讨论。对于单核和双核Ru II和Ru II